Skip to content

Conservative Treatment of Ingrown Toenail

Conservative Treatment of Ingrown Toenail in Stages I or IIa

Status
Completed
Phases
NA
Study type
Interventional
Source
ClinicalTrials.gov
Registry ID
NCT05214586
Acronym
TOCON
Enrollment
20
Registered
2022-01-28
Start date
2022-02-01
Completion date
2022-05-30
Last updated
2022-06-02

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Ingrown Nail, Nails, Abnormal

Keywords

Ingrown toenail, Conservative treatment, Recurrence, Podiatry, Nail remodelling

Brief summary

Ingrown toenail has become one of the most prevalent onychopathies and a frequent reason for consultation in podiatry clinics. In the initial stages of the pathology, conservative treatments are the first choice of therapy. The aim was therefore, to analyze and compare the efficacy of the technique of nail re-education with gauze bandage and nail remodelling for the conservative treatment of onychocryptosis in stage I and IIA, A prospective, longitudinal, randomised clinical trial-type analytical study is proposed. A sample of 20 subjects with stage I and IIA onychocryptosis will be selected. Of these, 10 cases were part of the gauze bandage nail re-education group and the remaining 10 cases were part of the nail remodelling group.

Interventions

PROCEDUREFollow up of the clinical stage

Pain, Swelling, Infection, Patient satisfaction and recurrence of the disease will be measured

Sponsors

University of Valencia
CollaboratorOTHER
Universidad de Extremadura
Lead SponsorOTHER

Study design

Allocation
RANDOMIZED
Intervention model
PARALLEL
Primary purpose
TREATMENT
Masking
NONE

Eligibility

Sex/Gender
ALL
Age
12 Years to 65 Years
Healthy volunteers
No

Inclusion criteria

* Ingrown toenail in stage I or IIa (Mozena Classification)

Exclusion criteria

* Patients not allowed for clinical follow-up of the evolution of the pathology. * Patients presented with deforming pathologies * Pattens had been surgically operated for ingrown toenail

Design outcomes

Primary

MeasureTime frameDescription
Recurrence of the disease3 monthsRecurrence is defined as a return of the previous symptoms, regrowth of the nail edge, or patient dissatisfaction with the clinical outcome.

Secondary

MeasureTime frameDescription
Reported painEvery clinic visit of the patient until 3 monthsVisual analogue scale of pain (0-10)
InfectionEvery clinic visit of the patient until 3 monthsPresence of infection symptoms as oozing or built up fluid around the affected area, bleeding, foul smell, overgrowth tissues around the edges of the toenail or abscess filled with puss.
SwellingEvery clinic visit of the patient until 3 monthsPresence of swelling symptoms as pain, redness and hardardening around the affected toenail.
Patient satisfactionEvery clinic visit of the patient until 3 monthsPatient satisfaction survey (0-10)

Countries

Spain

Outcome results

None listed

Source: ClinicalTrials.gov · Data processed: Feb 4, 2026